Tyrosine Kinase Inhibitors - Globe Thesis

Keyword [Tyrosine Kinase Inhibitors] Result: 101 - 120 \| Page: 6 of 10
101.	Analysis Of Efficacy And Related Factors Of Acquired Deep Molecular Response In Chronic Myeloid Leukemia Patients Treated With TKI
102.	Clinical And Molecular Genetic Study On Chronic Myeloid Leukemia Thrated By Second Generation Tyrosine Kinase Inhibitors
103.	Study On The Relationship Between Polymorphisms Of The CYP3A5 Gene And Crizotinib-induced Hepatotoxicity
104.	Role Of EMT In Radiosensitivity Of NSCLC With Acquired Resistance Of EGFR-TKI
105.	Study On Synthesis And Antitumor Activities Of New Type Of Small Molecules Pteridine
106.	Analysis Of The Efficacy After Discontinuation Of Tyrosine Kinase Inhibitors Treatment In Patients With Chronic Myelogenous Leukemia
107.	Outcomes Of Tyrosine Kinase Inhibitors Combined With Chemotherapy And Allogeneic Hematopoietic Stem Cell Transplantation In Philadelphia Chromosome-positive Adult Acute Lymphoblastic Leukemia
108.	Efficacy And Safety Of Stereotactic Body Radiation Therapy In The Management Of Oligopersistent Disease In Patients With Egfr Mutant Non-small Cell Lung Cancer During EGFR-TKIs Treatment
109.	Sequential Treatment Of EGFR Tyrosine Kinase Inhibitors And Platinum Doublet Chemotherapy On Survival Of Advanced Non-small-cell Lung Cancer With EGFR Mutations
110.	AP Versus DP Chemotherapy Regimen As Second-line Therapy In EGFR-TKIs Treated Advanced Non-small-cell Lung Cancer Patients With EGFR Mutations
111.	Functional Research Of Resistance Mutations To EGFR Or MET Tyrosine Kinase Inhibitors In Lung Adenocarcinoma Patients
112.	The Clinical Study And The Mechanism On The Reversion Of Acquired Resistance With The First Generation EGRF-TKIs For Advanced NSCLC Patients
113.	The Study Of Multi-target Tyrosine Kinase Inhibitors To Regulate C-Cbl Gene-mediated Chemoresistance In Acute Myeloid Leukemia Cells
114.	Proteomics In Non-Small Cell Lung Cancer Patients For Prediction Of Clinical Outcome After Treatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors And Chemotherapy
115.	Real-world Study Of Diagnosis,Treatment And Prognosis In Chinses Advanced Lung Cancer Patients With Rare Driver Mutations
116.	Characteristics And Survival In Non-small Cell Lung Cancer Patients Harbored Primary And Acquired EGFR T790M Mutation
117.	Metabolism And Clinical Pharmacokinetics Of Some Tyrosine Kinase Inhibitors
118.	The Progress Of The Study On Ph-like Acute Lymphoblastic Leukemia
119.	Retrospective Analysis Of Tyrosine Kinase Inhibitors In The Treatment Of Chronic Myeloid Leukemia
120.	Clinical And Genetic Factors Affecting The Efficacy Of Chronic Myeloid Leukemia In TKIs Era
<<First <Prev Next> Last>> Jump to